This medication is also used to help lower the risk of various cardiovascular diseases and worsening kidney disease (in patients with chronic kidney disease and type 2 diabetes)
2BD, Supplementary Table 1) is consistent with patients who abuse alcohol and whose cardiac dimensions are relatively unchanged despite disease manifestation during the asymptomatic phase 18
To avoid common pitfalls of stopping GLP-1s, adopt sustained healthy lifestyle habits that will support weight maintenance without the medication
In people with adequate B12 levels, additional supplementation does not enhance energy beyond normal physiological function
"For retatrutide, the findings from TRIUMPH-4 are encouraging, and with seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis," a Lilly spokesperson said in a statement to Fox News Digital
Millions of people may lose access to their obesity and diabetes medications overnight, potentially putting their health in jeopardy. Noom appreciates the Committee highlighting this issue and recommends a cautious approach before ending access to a large supply of affordable GLP-1s, which will only make GLP-1s more difficult to access
